Barclays PLC Reduces Stake in MultiPlan Co. (NYSE:MPLN)

Barclays PLC cut its holdings in shares of MultiPlan Co. (NYSE:MPLN - Free Report) by 64.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 100,000 shares of the company's stock after selling 180,000 shares during the period. Barclays PLC owned 0.62% of MultiPlan worth $1,478,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of MPLN. Empowered Funds LLC grew its holdings in MultiPlan by 5.0% during the 4th quarter. Empowered Funds LLC now owns 46,191 shares of the company's stock valued at $683,000 after buying an additional 2,188 shares in the last quarter. Beach Point Capital Management LP increased its holdings in MultiPlan by 9.2% in the fourth quarter. Beach Point Capital Management LP now owns 384,982 shares of the company's stock valued at $5,690,000 after buying an additional 32,582 shares in the last quarter. Oppenheimer & Co. Inc. purchased a new stake in MultiPlan during the 4th quarter worth approximately $292,000. Prudential Financial Inc. purchased a new stake in shares of MultiPlan in the fourth quarter valued at approximately $2,494,000. Finally, Geode Capital Management LLC grew its holdings in shares of MultiPlan by 17.3% during the 4th quarter. Geode Capital Management LLC now owns 67,615 shares of the company's stock worth $1,000,000 after purchasing an additional 9,954 shares during the period. 87.15% of the stock is currently owned by institutional investors.

MultiPlan Price Performance

Shares of MultiPlan stock traded up $0.35 on Friday, hitting $21.58. The company had a trading volume of 119,460 shares, compared to its average volume of 116,882. MultiPlan Co. has a 52 week low of $4.80 and a 52 week high of $31.01. The business has a 50-day simple moving average of $20.53 and a 200-day simple moving average of $16.02. The company has a market cap of $348.97 million, a PE ratio of -0.23 and a beta of 0.13. The company has a debt-to-equity ratio of 21.73, a current ratio of 1.05 and a quick ratio of 1.05.

Analyst Upgrades and Downgrades

Separately, Citigroup boosted their target price on MultiPlan from $10.00 to $12.50 and gave the company a "neutral" rating in a report on Friday, January 10th.

MultiPlan Company Profile

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.